aTyr Pharma

Last Updated Apr 22, 2025

Company Overview

Company Name

aTyr Pharma

About aTyr Pharma

aTyr Pharma is a clinical-stage biopharmaceutical company focused on developing a new class of medicines based on its proprietary tRNA synthetase biology. The company's lead product candidate, efzofitimod, is being evaluated in clinical trials for the treatment of pulmonary sarcoidosis and systemic sclerosis-associated interstitial lung disease.

Frequently Asked Questions about aTyr Pharma

Advertising Pixels

  • Facebook Ad Pixel
  • LinkedIn Ad Pixel

Technologies Used

Key Decision Makers

Ashlee Dunston Director, Investor Relations
LinkedIn
Lisa Carey Vice President Clinical Operations
LinkedIn
Brandis Rosenthal Clinical Trial Associate
LinkedIn
Melissa Meyer, MHA Sr. Manger, Clinical Trial Operations Supply Management
LinkedIn